Platelet-Endothelial Cell Adhesion Molecule-1 (PECAM-1, CD31, endoCAM) is a member of the immunoglobulin (Ig) superfamily present on platelets, endothelial cells and leukocytes. Despite recent data implicating PECAM-1 in angiogenesis, cardiovascular development and inflammation much remains to be learned about the adhesive interactions of PECAM-1 that underlie these important processes. Therefore the overall goal of this proposal is to advance our understanding of the molecular basis of PECAM-1-mediated adhesion. Recent published and preliminary data have suggested that 1) there are specific regions of the cytoplasmic domain that regulate not only the ability of PECAM-1 to support adhesion, but that define its ligand specificity and 2) a distinct region in the extracellular domain may mediate PECAM-1 homophilic adhesion (PECAM-1 to PECAM-1). To test these hypotheses, the following specific aims are proposed. 1. Characterization of the functional regions of the cytoplasmic domain that regulate the adhesive function of PECAM-1. To accomplish this, a series of mutants bearing deletions of specific regions of the cytoplasmic domain will be constructed and expressed in L-cell fibroblasts for functional analysis in an aggregation assay. The characteristics of L-cell aggregation mediated by each mutant will be determined and the mechanisms by which the cytoplasmic domain regulate PECAM-1-dependent adhesion will be studied. 2. Characterization of the homophilic binding domain of PECAM-1. To accomplish this, a series of mouse/human PECAM-1 chimeric receptors will be expressed in L-cells and subsequently tested for their ability to participate in homophilic interactions. Confirmation of the functional significance of the sequence(s) determined to be required for PECAM-1 homophilic binding will be achieved by studying the effect of peptides that mimic these residues in in vivo models of angiogenesis and inflammation. Not only will our studies provide specific informaiton about the structure- function relationships of PECAM-1, (information that may prove helpful in the development of new therapeutic agents for inflammation and cancer), we believe that they will also advance our understanding of the basic mechanisms of cell-cell adhesion.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Minority School Faculty Development Awards (K14)
Project #
1K14HL003382-01
Application #
2211627
Study Section
Special Emphasis Panel (ZHL1-CCT-L (F1))
Project Start
1995-07-01
Project End
2000-06-30
Budget Start
1995-07-01
Budget End
1996-06-30
Support Year
1
Fiscal Year
1995
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Rolaki, Alexandra; Coukos, George; Loutradis, Dimitris et al. (2007) Luteogenic hormones act through a vascular endothelial growth factor-dependent mechanism to up-regulate alpha 5 beta 1 and alpha v beta 3 integrins, promoting the migration and survival of human luteinized granulosa cells. Am J Pathol 170:1561-72
Savani, R C; Cao, G; Pooler, P M et al. (2001) Differential involvement of the hyaluronan (HA) receptors CD44 and receptor for HA-mediated motility in endothelial cell function and angiogenesis. J Biol Chem 276:36770-8
Savani, R C; Zhou, Z; Arguiri, E et al. (2000) Bleomycin-induced pulmonary injury in mice deficient in SPARC. Am J Physiol Lung Cell Mol Physiol 279:L743-50
Nakada, M T; Amin, K; Christofidou-Solomidou, M et al. (2000) Antibodies against the first Ig-like domain of human platelet endothelial cell adhesion molecule-1 (PECAM-1) that inhibit PECAM-1-dependent homophilic adhesion block in vivo neutrophil recruitment. J Immunol 164:452-62
DeLisser, H M (1999) Epitope mapping. Methods Mol Biol 96:11-20
DeLisser, H M; Christofidou-Solomidou, M; Sun, J et al. (1999) Loss of endothelial surface expression of E-selectin in a patient with recurrent infections. Blood 94:884-94
Christofidou-Solomidou, M; Nakada, M T; Williams, J et al. (1997) Neutrophil platelet endothelial cell adhesion molecule-1 participates in neutrophil recruitment at inflammatory sites and is down-regulated after leukocyte extravasation. J Immunol 158:4872-8
DeLisser, H M; Christofidou-Solomidou, M; Strieter, R M et al. (1997) Involvement of endothelial PECAM-1/CD31 in angiogenesis. Am J Pathol 151:671-7
Famiglietti, J; Sun, J; DeLisser, H M et al. (1997) Tyrosine residue in exon 14 of the cytoplasmic domain of platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31) regulates ligand binding specificity. J Cell Biol 138:1425-35
Sun, J; Williams, J; Yan, H C et al. (1996) Platelet endothelial cell adhesion molecule-1 (PECAM-1) homophilic adhesion is mediated by immunoglobulin-like domains 1 and 2 and depends on the cytoplasmic domain and the level of surface expression. J Biol Chem 271:18561-70

Showing the most recent 10 out of 11 publications